Institute of Clinical Pharmacology, Anhui Medical University, Hefei, Anhui, China (mainland).
Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China (mainland).
Med Sci Monit. 2020 May 24;26:e923688. doi: 10.12659/MSM.923688.
BACKGROUND Emerging evidence shows that Sirtuin 3 (SIRT3) can exert an antioxidative effect in various neurodegenerative diseases, but whether and how SIRT3 modulates neuronal death after subarachnoid hemorrhage (SAH) remains to be elucidated. MATERIAL AND METHODS Experimental SAH was induced in adult mice by prechiasmatic cistern injection and primary neurons by OxyHb incubation. The peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) and SIRT3 protein levels were examined at different time points after SAH induction. The PGC-1alpha protein gene knockdown in vivo and in vitro was achieved by transfection of lentivirus (LV) vectors expressing shPGC-1alpha or negative control (NC). Western blot, oxidative stress index, histopathology, neurological function, and cell viability analysis was performed. RESULTS Results showed that the PGC-1alpha/SIRT3 pathway was remarkably activated in vivo and in vitro after SAH. LV-shPGC-1alpha treatment significantly inhibited the activation of this pathway after SAH, accompanied by deteriorated neurologic function, aggravated oxidative stress, increased neuronal apoptosis, and enhanced cytotoxicity compared with the mice or primary neurons treated with LV-NC only. CONCLUSIONS The present results highlight the detrimental PGC-1alpha/SIRT3 pathway, involving regulation of the endogenous antioxidant activity against neuronal damage, which may provide a potential therapeutic target in SAH.
越来越多的证据表明,Sirtuin 3(SIRT3)可以在各种神经退行性疾病中发挥抗氧化作用,但 SIRT3 是否以及如何调节蛛网膜下腔出血(SAH)后神经元死亡仍有待阐明。
通过视交叉前池注射诱导成年小鼠实验性 SAH,通过 OxyHb 孵育诱导原代神经元。在诱导 SAH 后不同时间点检查过氧化物酶体增殖物激活受体γ共激活因子 1-α(PGC-1α)和 SIRT3 蛋白水平。通过转染表达 shPGC-1α 或阴性对照(NC)的慢病毒(LV)载体实现 PGC-1α 蛋白基因的体内和体外敲低。进行 Western blot、氧化应激指数、组织病理学、神经功能和细胞活力分析。
结果表明,SAH 后体内和体外的 PGC-1α/SIRT3 通路明显被激活。LV-shPGC-1α 治疗显著抑制了 SAH 后的通路激活,与仅用 LV-NC 处理的小鼠或原代神经元相比,神经功能恶化、氧化应激加重、神经元凋亡增加和细胞毒性增强。
本研究结果强调了有害的 PGC-1α/SIRT3 通路,涉及调节内源性抗氧化活性以防止神经元损伤,这可能为 SAH 提供潜在的治疗靶点。